|
TJAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.554100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.769800E-01 |
| Normal-vs-Stage2 |
2.157600E-01 |
| Normal-vs-Stage3 |
1.624180E-01 |
| Normal-vs-Stage4 |
7.230800E-01 |
| Stage1-vs-Stage2 |
1.946380E-01 |
| Stage1-vs-Stage3 |
1.381230E-01 |
| Stage1-vs-Stage4 |
8.437800E-01 |
| Stage2-vs-Stage3 |
8.956400E-01 |
| Stage2-vs-Stage4 |
1.792370E-01 |
| Stage3-vs-Stage4 |
1.300180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.261000E-01 |
| Normal-vs-AfricanAmerican |
1.799580E-01 |
| Normal-vs-Asian |
8.096600E-01 |
| Caucasian-vs-AfricanAmerican |
2.863000E-01 |
| Caucasian-vs-Asian |
8.415000E-01 |
| AfricanAmerican-vs-Asian |
2.450600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.877800E-01 |
| Normal-vs-Female |
5.425600E-02 |
| Male-vs-Female |
8.095000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.442000E-01 |
| Normal-vs-Extreme_Weight |
6.504600E-01 |
| Normal-vs-Obese |
8.058300E-02 |
| Normal-vs-Extreme_Obese |
8.782000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.960600E-01 |
| Normal_Weight-vs-Obese |
1.456440E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.403000E-01 |
| Extreme_Weight-vs-Obese |
1.856240E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.259000E-01 |
| Obese-vs-Extreme_Obese |
1.144800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.134200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.721230E-01 |
| Normal-vs-Age(61-80Yrs) |
2.523800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.665600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.177200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.132230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.261700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.449600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.697600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.836200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.136300E-02 |
| Normal-VS-Type2 PRCC |
6.515800E-01 |
| Normal-VS-KIRP CIMP |
2.726000E-01 |
| Normal-VS-Unclassified PRCC |
8.421800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.002200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.079200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.337760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.726000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.758600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.011400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.771400E-01 |
| Normal-vs-N1 |
1.839840E-01 |
| Normal-vs-N2 |
1.692810E-01 |
| N0-vs-N1 |
2.176200E-01 |
| N0-vs-N2 |
4.682400E-01 |
| N1-vs-N2 |
1.131040E-01 |
|
|
